$GALT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GALECTIN THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GALECTIN THERAPEUTICS INC. Get notifications about new insider transactions in GALECTIN THERAPEUTICS INC for free.
Page: < prev 1 2 3 4 5 6 7 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 95,000 | 285,000 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 51,667 | 155,001 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 55,834 | 167,502 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 54,167 | 162,501 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 54,167 | 162,501 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 51,666 | 154,998 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 54,166 | 162,498 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 50,000 | 150,000 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 33,333 | 99,999 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 95,000 | 285,000 | 2,776,186 | 2.7 M to 2.8 M (+3.54 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 51,667 | 155,001 | 2,681,186 | 2.6 M to 2.7 M (+1.96 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 55,834 | 167,502 | 2,629,519 | 2.6 M to 2.6 M (+2.17 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 54,167 | 162,501 | 2,573,685 | 2.5 M to 2.6 M (+2.15 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 54,167 | 162,501 | 2,519,518 | 2.5 M to 2.5 M (+2.20 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 51,666 | 154,998 | 2,465,351 | 2.4 M to 2.5 M (+2.14 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 54,166 | 162,498 | 2,413,685 | 2.4 M to 2.4 M (+2.30 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 50,000 | 150,000 | 2,359,519 | 2.3 M to 2.4 M (+2.16 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 33,333 | 99,999 | 2,309,519 | 2.3 M to 2.3 M (+1.46 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 95,000 | 285,000 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 51,667 | 155,001 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 55,834 | 167,502 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 54,167 | 162,501 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 54,167 | 162,501 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 51,666 | 154,998 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 54,166 | 162,498 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 50,000 | 150,000 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 33,333 | 99,999 | 0 | |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 95,000 | 285,000 | 2,776,186 | 2.7 M to 2.8 M (+3.54 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 51,667 | 155,001 | 2,681,186 | 2.6 M to 2.7 M (+1.96 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 55,834 | 167,502 | 2,629,519 | 2.6 M to 2.6 M (+2.17 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 54,167 | 162,501 | 2,573,685 | 2.5 M to 2.6 M (+2.15 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 54,167 | 162,501 | 2,519,518 | 2.5 M to 2.5 M (+2.20 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 51,666 | 154,998 | 2,465,351 | 2.4 M to 2.5 M (+2.14 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 54,166 | 162,498 | 2,413,685 | 2.4 M to 2.4 M (+2.30 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 50,000 | 150,000 | 2,359,519 | 2.3 M to 2.4 M (+2.16 %) |
Jan 29 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 33,333 | 99,999 | 2,309,519 | 2.3 M to 2.3 M (+1.46 %) |
Jan 24 2014 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | A | 13.38 | 10,000 | 133,800 | 10,000 | |
Jan 24 2014 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | A | 13.38 | 26,000 | 347,880 | 26,000 | |
Jan 24 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | A | 13.38 | 61,000 | 816,180 | 61,000 | |
Jan 24 2014 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | A | 13.38 | 38,000 | 508,440 | 38,000 | |
Jan 24 2014 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President and CEO | Option Exercise | A | 13.38 | 134,000 | 1,792,920 | 134,000 | |
Jan 14 2014 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Sell | S | 14.00 | 58,000 | 812,203 | 9,357,422 | 9.4 M to 9.4 M (-0.62 %) |
Jan 14 2014 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Sell | S | 16.00 | 42,000 | 672,118 | 9,415,422 | 9.5 M to 9.4 M (-0.44 %) |
Jan 14 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Sell | S | 14.00 | 58,000 | 812,203 | 9,357,422 | 9.4 M to 9.4 M (-0.62 %) |
Jan 14 2014 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Sell | S | 16.00 | 42,000 | 672,118 | 9,415,422 | 9.5 M to 9.4 M (-0.44 %) |
Jan 14 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 14.00 | 58,000 | 812,203 | 9,357,422 | 9.4 M to 9.4 M (-0.62 %) |
Jan 14 2014 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 16.00 | 42,000 | 672,118 | 9,415,422 | 9.5 M to 9.4 M (-0.44 %) |
Jan 13 2014 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 2.32 | 50,000 | 116,000 | 100,000 | |
Jan 13 2014 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Payment of Exercise | F | 13.49 | 8,598 | 115,996 | 95,316 | 103.9 K to 95.3 K (-8.27 %) |
Jan 13 2014 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 2.32 | 50,000 | 116,000 | 103,914 | 53.9 K to 103.9 K (+92.74 %) |
Jan 02 2014 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 8.01 | 618 | 4,950 | 18,074 | 17.5 K to 18.1 K (+3.54 %) |
Dec 10 2013 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President and CEO | Buy | P | 8.90 | 500 | 4,450 | 96,333 | 95.8 K to 96.3 K (+0.52 %) |
Dec 05 2013 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President and CEO | Buy | P | 9.00 | 500 | 4,500 | 95,833 | 95.3 K to 95.8 K (+0.52 %) |
Dec 04 2013 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | P | 8.69 | 3,000 | 26,070 | 6,334 | 3.3 K to 6.3 K (+89.98 %) |
Dec 03 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 8.20 | 609 | 4,992 | 17,456 | 16.8 K to 17.5 K (+3.61 %) |
Nov 19 2013 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Buy | P | 6.25 | 260 | 1,625 | 260 | 0 to 260 |
Nov 19 2013 | GALT | GALECTIN THERAPEUT ... | Greenberg Arthur | Director | Buy | P | 6.55 | 2,000 | 13,102 | 95,667 | 93.7 K to 95.7 K (+2.14 %) |
Nov 19 2013 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President and CEO | Buy | P | 5.53 | 1,000 | 5,530 | 95,333 | 94.3 K to 95.3 K (+1.06 %) |
Nov 19 2013 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | P | 6.63 | 500 | 3,315 | 53,914 | 53.4 K to 53.9 K (+0.94 %) |
Nov 19 2013 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 6.08 | 1,000 | 6,078 | 2,917 | 1.9 K to 2.9 K (+52.16 %) |
Nov 19 2013 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President and CEO | Buy | P | 5.80 | 1,000 | 5,799 | 511,000 | 510 K to 511 K (+0.20 %) |
Nov 18 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | P | 6.90 | 1,000 | 6,897 | 844,450 | 843.5 K to 844.5 K (+0.12 %) |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 50,000 | 150,000 | 33,333 | |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 150,000 | 450,000 | 0 | |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 50,000 | 150,000 | 9,457,422 | 9.4 M to 9.5 M (+0.53 %) |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 150,000 | 450,000 | 9,407,422 | 9.3 M to 9.4 M (+1.62 %) |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | M | 3.00 | 50,000 | 150,000 | 33,333 | |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | M | 3.00 | 150,000 | 450,000 | 0 | |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Buy | M | 3.00 | 50,000 | 150,000 | 9,457,422 | 9.4 M to 9.5 M (+0.53 %) |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Buy | M | 3.00 | 150,000 | 450,000 | 9,407,422 | 9.3 M to 9.4 M (+1.62 %) |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 50,000 | 150,000 | 33,333 | |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 150,000 | 450,000 | 0 | |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 50,000 | 150,000 | 9,457,422 | 9.4 M to 9.5 M (+0.53 %) |
Nov 05 2013 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 150,000 | 450,000 | 9,407,422 | 9.3 M to 9.4 M (+1.62 %) |
Nov 04 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 10.43 | 478 | 4,985 | 16,847 | 16.4 K to 16.8 K (+2.92 %) |
Oct 18 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | M | 3.00 | 300,000 | 900,000 | 0 | |
Oct 18 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Buy | M | 3.00 | 300,000 | 900,000 | 9,257,422 | 9 M to 9.3 M (+3.35 %) |
Oct 18 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | M | 3.00 | 300,000 | 900,000 | 0 | |
Oct 18 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | M | 3.00 | 300,000 | 900,000 | 9,257,422 | 9 M to 9.3 M (+3.35 %) |
Oct 18 2013 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Option Exercise | M | 3.00 | 300,000 | 900,000 | 0 | |
Oct 18 2013 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Buy | M | 3.00 | 300,000 | 900,000 | 9,257,422 | 9 M to 9.3 M (+3.35 %) |
Oct 09 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Sell | S | 12.36 | 12,000 | 148,270 | 8,957,422 | 9 M to 9 M (-0.13 %) |
Oct 09 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Sell | S | 11.79 | 100,000 | 1,179,160 | 8,969,422 | 9.1 M to 9 M (-1.10 %) |
Oct 09 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Sell | S | 12.36 | 12,000 | 148,270 | 8,957,422 | 9 M to 9 M (-0.13 %) |
Oct 09 2013 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Sell | S | 11.79 | 100,000 | 1,179,160 | 8,969,422 | 9.1 M to 9 M (-1.10 %) |
Oct 09 2013 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 12.36 | 12,000 | 148,270 | 8,957,422 | 9 M to 9 M (-0.13 %) |
Oct 09 2013 | GALT | GALECTIN THERAPEUT ... | 10X Fund, L.P. | 10% Owner | Sell | S | 11.79 | 100,000 | 1,179,160 | 8,969,422 | 9.1 M to 9 M (-1.10 %) |
Oct 03 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 9.97 | 125 | 1,246 | 16,369 | 16.2 K to 16.4 K (+0.77 %) |
Oct 03 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 9.96 | 376 | 3,746 | 16,244 | 15.9 K to 16.2 K (+2.37 %) |
Sep 06 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 7.38 | 676 | 4,988 | 15,868 | 15.2 K to 15.9 K (+4.45 %) |
Aug 06 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 5.94 | 840 | 4,988 | 15,192 | 14.4 K to 15.2 K (+5.85 %) |
Jul 08 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 4.23 | 876 | 3,709 | 14,352 | 13.5 K to 14.4 K (+6.50 %) |
Jul 03 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 4.24 | 300 | 1,273 | 13,476 | 13.2 K to 13.5 K (+2.28 %) |
Jul 02 2013 | GALT | GALECTIN THERAPEUT ... | CALLICUTT JACK W | Chief Financial Off ... | Option Exercise | A | 4.41 | 200,000 | 882,000 | 200,000 | |
Jun 21 2013 | GALT | GALECTIN THERAPEUT ... | MCGAULEY THOMAS | Chief Financial Off ... | Option Exercise | A | 3.97 | 25,000 | 99,250 | 25,000 | |
Jun 04 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 4.21 | 1,176 | 4,954 | 13,176 | 12 K to 13.2 K (+9.80 %) |
May 30 2013 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Buy | P | 4.21 | 1,000 | 4,212 | 6,500 | 5.5 K to 6.5 K (+18.18 %) |
May 01 2013 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | M | 2.32 | 100,000 | 232,000 | 150,000 | |
May 01 2013 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Payment of Exercise | F | 4.98 | 46,586 | 231,998 | 53,414 | 100 K to 53.4 K (-46.59 %) |
May 01 2013 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Buy | M | 2.32 | 100,000 | 232,000 | 100,000 | 0 to 100 K |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | ROME JERALD K | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | PRESSLER HERMAN PAUL | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | Prelack Steven | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | Greenberg Arthur | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | FREEMAN KEVIN D | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Apr 01 2013 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Option Exercise | A | 3.59 | 16,714 | 60,003 | 16,714 | |
Mar 14 2013 | GALT | GALECTIN THERAPEUT ... | Prelack Steven | Director | Option Exercise | M | 2.28 | 1,167 | 2,661 | 0 | |
Mar 14 2013 | GALT | GALECTIN THERAPEUT ... | Prelack Steven | Director | Payment of Exercise | F | 4.22 | 631 | 2,663 | 2,936 | 3.6 K to 2.9 K (-17.69 %) |
Mar 14 2013 | GALT | GALECTIN THERAPEUT ... | Prelack Steven | Director | Buy | M | 2.28 | 1,167 | 2,661 | 3,567 | 2.4 K to 3.6 K (+48.63 %) |
Mar 11 2013 | GALT | GALECTIN THERAPEUT ... | ROME JERALD K | Director | Option Exercise | M | 2.28 | 2,500 | 5,700 | 0 | |
Mar 11 2013 | GALT | GALECTIN THERAPEUT ... | ROME JERALD K | Director | Buy | M | 2.28 | 2,500 | 5,700 | 22,058 | 19.6 K to 22.1 K (+12.78 %) |
Oct 15 2012 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President and CEO | Buy | P | 2.11 | 2,500 | 5,287 | 510,000 | 507.5 K to 510 K (+0.49 %) |
Oct 10 2012 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President and CEO | Buy | P | 2.00 | 2,500 | 5,000 | 507,500 | 505 K to 507.5 K (+0.50 %) |
Oct 09 2012 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President and CEO | Buy | P | 2.07 | 5,000 | 10,350 | 505,000 | 500 K to 505 K (+1.00 %) |
Aug 29 2012 | GALT | GALECTIN THERAPEUT ... | Shlevin Harold H. | Chief Operating Off ... | Option Exercise | A | 2.32 | 250,000 | 580,000 | 250,000 | |
Jul 20 2012 | GALT | GALECTIN THERAPEUT ... | Greenberg Arthur | Director | Buy | P | 1.84 | 5,000 | 9,200 | 94,667 | 89.7 K to 94.7 K (+5.58 %) |
Jun 21 2012 | GALT | GALECTIN THERAPEUT ... | AMELIO GILBERT F | Director | Buy | P | 2.10 | 7,500 | 15,750 | 92,084 | 84.6 K to 92.1 K (+8.87 %) |
May 25 2012 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Buy | P | 2.44 | 5,000 | 12,200 | 91,488 | 86.5 K to 91.5 K (+5.78 %) |
May 25 2012 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | CEO and President | Option Exercise | A | 2.08 | 420,000 | 873,600 | 420,000 | |
May 18 2012 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | P | 2.25 | 10,000 | 22,500 | 843,450 | 833.5 K to 843.5 K (+1.20 %) |
May 25 2012 | GALT | GALECTIN THERAPEUT ... | MCGAULEY THOMAS | Chief Financial Off ... | Option Exercise | A | 2.08 | 10,000 | 20,800 | 10,000 | |
May 25 2012 | GALT | GALECTIN THERAPEUT ... | MCGAULEY THOMAS | Chief Financial Off ... | Buy | P | 2.35 | 10,000 | 23,500 | 10,000 | 0 to 10 K |
Apr 26 2012 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 3.08 | 1,100 | 3,388 | 4,947 | 3.8 K to 4.9 K (+28.59 %) |
Apr 26 2012 | GALT | GALECTIN THERAPEUT ... | MAULDIN JOHN F | Director | Buy | P | 2.94 | 3,847 | 11,310 | 3,847 | 0 to 3.8 K |
Apr 18 2012 | GALT | GALECTIN THERAPEUT ... | Greenberg Arthur | Director | Buy | P | 2.84 | 3,000 | 8,520 | 89,667 | 86.7 K to 89.7 K (+3.46 %) |
Apr 26 2012 | GALT | GALECTIN THERAPEUT ... | PRESSLER HERMAN PAUL | Director | Buy | P | 3.10 | 5,000 | 15,515 | 9,500 | 4.5 K to 9.5 K (+111.11 %) |
Oct 20 2011 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | P | 0.96 | 20,000 | 19,200 | 20,000 | 0 to 20 K |
Oct 14 2011 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 0.97 | 98,970 | 96,001 | 98,970 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | X | 0.50 | 570,000 | 285,000 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | X | 0.50 | 310,000 | 155,000 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | X | 0.50 | 335,000 | 167,500 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | X | 0.50 | 325,000 | 162,500 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | X | 0.50 | 325,000 | 162,500 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | X | 0.50 | 310,000 | 155,000 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Option Exercise | X | 0.50 | 235,000 | 117,500 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Grant | A | 1.00 | 6,000 | 6,000 | 179,232 | 173.2 K to 179.2 K (+3.46 %) |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | J | 0.92 | 206,724 | 190,186 | 9,069,422 | 8.9 M to 9.1 M (+2.33 %) |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Buy | X | 0.50 | 2,410,000 | 1,205,000 | 8,862,698 | 6.5 M to 8.9 M (+37.35 %) |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Gift | G | 1.08 | 2,000 | 2,160 | 4,065,268 | 4.1 M to 4.1 M (-0.05 %) |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Gift | G | 1.08 | 10,000 | 10,800 | 4,067,268 | 4.1 M to 4.1 M (-0.25 %) |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Gift | G | 1.08 | 10,000 | 10,800 | 4,077,268 | 4.1 M to 4.1 M (-0.24 %) |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | CZIRR JAMES C | Executive Chairman | Gift | G | 1.08 | 10,000 | 10,800 | 4,087,268 | 4.1 M to 4.1 M (-0.24 %) |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | X | 0.50 | 570,000 | 285,000 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | X | 0.50 | 310,000 | 155,000 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | X | 0.50 | 335,000 | 167,500 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | X | 0.50 | 325,000 | 162,500 | 0 | |
Oct 06 2011 | GALT | GALECTIN THERAPEUT ... | Martin Rod D | Director | Option Exercise | X | 0.50 | 325,000 | 162,500 | 0 |